Brought to you by:
Surmodics announces commercial release of Pounce XL thrombectomy system
Surmodics has announced the commercial release of the Pounce XL thrombectomy system for endovascular removal of acute or chronic clot from peripheral arteries. Intended for removal of thrombi and emboli from peripheral arteries ranging from 5.5–10mm in diameter, sizes typical of…
Gore announces FDA approval and first commercial implant of large-diameter thoracic tapers
Gore recently announced the expansion of the Gore Tag conformable thoracic stent graft with Active Control system product line, following Food and Drug Administration (FDA) approval of four new large-diameter tapered designs: 34x28mm, 37x31mm, 40x34mm and 45x37mm. News of the…
SCVS 2025: TBE device provides ‘safer’ option than TEVAR for blunt thoracic injuries in setting of zone 2 coverage
Use of the Gore Tag thoracic branch endoprosthesis (TBE) “offers a safer alternative” to traditional thoracic endovascular aortic repair (TEVAR) with left subclavian artery (LSA) coverage in blunt thoracic aortic injury (BTAI) requiring zone 2 coverage for zone 2 or…
ACC.25: Semaglutide improves walk distance for PAD patients with diabetes
Semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease (PAD) and type 2 diabetes in a trial designed to evaluate the use of a GLP-1 agonist to manage PAD. In addition to improvements in walking ability…
SCVS 2025: Multicenter data show favorable role for FEVAR over chimney grafts
A multi-institutional analysis has demonstrated fenestrated endovascular aneurysm repair (FEVAR) could be a “safer and more durable option” than chimney EVAR (ChEVAR) in elective juxtarenal abdominal aortic aneurysm (AAA) cases with suitable anatomy, offering potentially “greater generalizability to real-world practice.”…
One-year WAVE trial results show patency advantage for Wrapsody versus PTA
Merit Medical Systems has announced that the six-month results from the randomized arm of the Wrapsody arteriovenous access efficacy—WAVE—trial are scheduled for publication in the April issue of Kidney International, ahead of the presentation of 12-month results from the trial…
Study details radiation exposure learning curve among vascular trainees
The importance of radiation safety training for vascular surgery trainees was highlighted by a recent study that detailed a learning curve effect between first- and second-year fellows performing fluoroscopically guided interventions. Using optically stimulated dosimeters fitted outside and under lead…
Imperative Care expands Symphony thrombectomy portfolio with new FDA approval
Imperative Care today announced Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony 16F catheter, the company’s latest innovation designed to elevate care for patients with venous thrombosis. The company also announced the successful completion…
EVC 2025: Multidisciplinary, multi-stakeholder efforts key to setting venous disease research priorities
Addressing the audience at the 28th European Vascular Course (EVC 2025) in Maastricht, The Netherlands (March 9–11), Ulka Sachdev-Ost, MD, from the University of Pittsburgh Medical Center (UPMC) in Pittsburgh, Pennsylvania, set out a method to ensure limited funding is…
Novel thrombectomy system for VTE used successfully in first tranche of first-in-human cases
SonoVascular has announced the successful completion of an initial set of eight deep vein thrombosis (DVT) cases using its SonoThrombectomy system as part of a first-in-human (FIH) study of the device. All cases achieved a complete Marder score reduction as…